Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carreras

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Journal of Veterinary Internal Medicine|December 26, 2006
Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004)R E Risbon, L P de Lorimier, K Skorupski, et al.
Gut|December 10, 2009
Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac diseaseH Liu, R Brais, A Lavergne-Slove, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2026
SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytesG Oses, C Clavell, B González-Farré, et al.
Bone Marrow Transplantation|February 5, 2008
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcomaS L Gardner, J Carreras, C Boudreau, et al.
Vaccine|November 29, 2022
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort studyC Willame, C Dodd, C E Durán, et al.
Oncogene|June 6, 2017
Pancreatic cancer heterogeneity and response to Mek inhibitionK Pedersen, F Bilal, C Bernadó Morales, et al.
Journal of Chemotherapy (Florence, Italy)|March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitalsHéctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Veterinary and Comparative Oncology|January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumoursC London, T Mathie, N Stingle, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Journal of Veterinary Internal Medicine|December 26, 2006
Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004)R E Risbon, L P de Lorimier, K Skorupski, et al.
Gut|December 10, 2009
Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac diseaseH Liu, R Brais, A Lavergne-Slove, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2026
SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytesG Oses, C Clavell, B González-Farré, et al.
Bone Marrow Transplantation|February 5, 2008
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcomaS L Gardner, J Carreras, C Boudreau, et al.
Vaccine|November 29, 2022
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort studyC Willame, C Dodd, C E Durán, et al.
Oncogene|June 6, 2017
Pancreatic cancer heterogeneity and response to Mek inhibitionK Pedersen, F Bilal, C Bernadó Morales, et al.
Journal of Chemotherapy (Florence, Italy)|March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitalsHéctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Veterinary and Comparative Oncology|January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumoursC London, T Mathie, N Stingle, et al.
Pageof 12